Skip to content

Clinical trials

Influenza, Human trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Influenza, Human Country / region: Japan Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20097
20103
20111
20122
20134
20141
20152
20162
20171
20192
20201
20211
20221
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Recruiting2
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline7
UMN Pharma Inc.6
Alachua Government Services, Inc.2
Hoffmann-La Roche2
Sanofi Pasteur, a Sanofi Company2
AstraZeneca1
Chiba University1
Daiichi Sankyo Co., Ltd.1
Janssen Research & Development, LLC1
Kameda Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Influenza, Human32
COVID-195
Respiratory Tract Infections4
Infections2
Lung Diseases2
Pneumonia2
Severe Acute Respiratory Syndrome2
Virus Diseases2
Common Cold1
Community-Acquired Pneumonia1

Trials

Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.